Transgenic plants: A 5-year update on oral antipathogen vaccine development

Expert Review of Vaccines

Volumn 13, Issue 12, 2014, Pages 1523-1536

  Hernández, Marisela ^a   Rosas, Gabriela ^b   Cervantes, Jacquelynne ^a   Fragoso, Gladis ^a   Rosales Mendoza, Sergio ^b   Sciutto, Edda ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MORELOS   (Mexico)

Author keywords

Delivery system; Marker free system; Oral immunization; Transgenic plant; Transplastomic technology; Vaccine; Viral expression vector

Indexed keywords

ELASTIN LIKE POLYPEPTIDE; HYBRID PROTEIN; HYDROPHOBIN; HYDROPHOBIN I; POLYPEPTIDE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VACCINE; VIRUS VECTOR; EDIBLE VACCINE;

ANTIGEN EXPRESSION; BACTERIUM; BIOSAFETY; DNA VIRUS; DRUG DELIVERY SYSTEM; HUMAN; IMMUNOGENICITY; INFECTION; INFECTION PREVENTION; MARKER GENE; MUCOSAL IMMUNITY; NONHUMAN; ORAL VACCINATION; PARASITE; PHASE 1 CLINICAL TRIAL (TOPIC); REVIEW; RNA VIRUS; TRANSGENIC PLANT; TRANSGENICS; TRANSPLASTOMICS; VACCINATION; VACCINE PRODUCTION; VIRUS; VIRUS EXPRESSION; VIRUS LIKE AGENT; DRUG DEVELOPMENT; GENETICS; IMMUNOLOGY; ORAL DRUG ADMINISTRATION; PROCEDURES; TRENDS;

ADMINISTRATION, ORAL; DRUG DISCOVERY; IMMUNITY, MUCOSAL; PLANTS, GENETICALLY MODIFIED; VACCINATION; VACCINES, EDIBLE;

EID: 84909585766     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.2014.953064     Document Type: Review

References (132)

1. Curtiss R 3rd, Cardineau GA. US5679880 A; 1997
2. Bock R. Engineering chloroplasts for high-level foreign protein expression. Methods Mol Biol 2014;1132:93-106
3. Jacob SS, Cherian S, Sumithra TG, et al. Edible vaccines against veterinary parasitic diseases - current status and future prospects. Vaccine 2013;31(15):1879-85
4. Rosales-Mendoza S, Salazar-González JA. Immunological aspects of using plant cells as delivery vehicles for oral vaccines. Expert Rev Vaccines. 2014. [Epub ahead of print]
5. Specht EA, Mayfield SP. Algae-based oral recombinant vaccines. Front Microbiol 2014;5:60
6. Guan ZJ, Guo B, Huo YL, et al. Recent advances and safety issues of transgenic plant-derived vaccines. Appl Microbiol Biotechnol 2013;97(7):2817-40
7. Ahmad A, Pereira EO, Conley AJ, et al. Green biofactories: recombinant protein production in plants. Recent Pat Biotechnol 2010;4(3):242-59
8. Lugade AA, Kalathil S, Heald JL, Thanavala Y. Transgenic plant-based oral vaccines. Immunol Invest 2010;39(4-5):468-82
9. Kim SH, Jang YS. Antigen targeting to M cells for enhancing the efficacy of mucosal vaccines. Exp Mol Med 2014;46:e85
10. Meeusen EN. Exploiting mucosal surfaces for the development of mucosal vaccines. Vaccine 2011;29(47):8506-11
11. Owen JL, Sahay B, Mohamadzadeh M. New generation of oral mucosal vaccines targeting dendritic cells. Curr Opin Chem Biol 2013;17(6):918-24
12. Pavot V, Rochereau N, Genun C, et al. New insights in mucosal vaccine development. Vaccine 2012;30(2):142-54
13. Gupta PN, Vyas SP. Investigation of lectinized liposomes as M-cell targeted carrier-adjuvant for mucosal immunization. Colloids Surf B Biointerfaces 2011;82(1):118-25
14. Otczky DC, Cripps AW. Mucosal immunization: a realistic alternative. Hum Vacinn 2010;6(12):978-1006
15. Fujihashi K, Kato H, van Ginkel FW, et al. A revisit of mucosal IgA immunity and oral tolerance. Acta Odontol Scand 2001;59(5):301-8
16. Yamamoto M, Pascual DW, Kiyono H. M cell-targeted mucosal vaccine strategies. Curr Top Microbiol Immunol 2012;354:39-52
17. Fujkuyama Y, Tokuhara D, Hataoka K, et al. Novel vaccine development strategies for inducing mucosal immunity. Expert Rev Vaccines 2012;11(3):367-79
18. Mason HS, Herbst-Kralovetz MM. Plant-derived antigens as mucosal vaccines. Curr Top Microbiol Immunol 2012;354:101-20
19. Pniewski T. The twenty-year story of a plant-based vaccine against hepatitis B: stagnation or promising prospects? Int J Mol Sci 2013;14(1):1978-98
20. Kwon KC, Verma D, Singh ND, et al. Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells. Adv Drug Deliv Rev 2013;65(6):782-99
21. Boothe JG, Saponja JA, Parmenter DL. Molecular farming in plants: oilseeds as vehicles for the production of pharmaceutical proteins. Drug Dev Res 1997;42(3-4):172-81
22. Karg SR, Kallio PT. The production of biopharmaceuticals in plant systems. Biotechnol Adv 2009;27(6):879-94
23. Khan I, Twyman RM, Arcalis E, Stoger E. Using storage organelles for the accumulation and encapsulation of recombinant proteins. Biotechnol J 2012;7(9):1099-108
24. Lamphear BJ, Streatfield SJ, Jilka JM, et al. Delivery of subunit vaccines in maize seed. J Control Release 2002;85(1-3):169-80
25. Bock R. Genetic engineering of the chloroplast: novel tools and new applications. Curr Opin Biotechnol 2014;26:7-13
26. Oey M, Lohse M, Kreikemeyer B, Bock R. Exhaustion of the chloroplast protein synthesis capacity by massive expression of a highly stable protein antibiotic. Plant J 2009;57(3):436-45
27. Hagemann R. The sexual inheritance of plant organelles. In: Daniell H, Chase C, editors. Molecular biology and biotechnology of plant organelles. Springer Publishers; The Netherlands: 2004. p. 93-113
28. Maliga P. Plastid transformation in higher plants. Annu Rev Plant Biol 2004;55:289-313
29. Arai Y, Shikanai T, Doi Y, et al. Production of polyhydroxybutyrate by polycistronic expression of bacterial genes in tobacco plastid. Plant Cell Physiol 2004;45(9):1176-84
30. Scharff LB, Bock R. Emerging tools for synthetic biology in plants. Plant J 2013. [Epub ahead of print]
31. Oliveira PH, Mairhofer J. Marker-free plasmids for biotechnological applications - implications and perspectives. Trends Biotechnol 2013;31(9):539-47
32. Li B, Xie C, Qiu H. Production of selectable marker-free transgenic tobacco plants using a non-selection approach: chimerism or escape, transgene inheritance, and efficiency. Plant Cell Rep 2009;28(3):373-86
33. Manimaran P, Ramkumar G, Sakthivel K, et al. Suitability of non-lethal marker and marker-free systems for development of transgenic crop plants: present status and future prospects. Biotechnol Adv 2011;29(6):703-14
34. Penna S, Ganapathi TR. Engineering the plant genome. Prospects of selection systems using non-antibiotic marker genes. GM Crops 2010;1(3):128-36
35. Tuteja N, Verma S, Sahoo RK, et al. Recent advances in development of marker-free transgenic plants: regulation and biosafety concern. J Biosci 2012;37(1):167-97
36. Gutiérrez SP, Saberianfar R, Kohalmi SE, Menassa R. Protein body formation in stable transgenic tobacco expressing elastin-like polypeptide and hydrophobin fusion proteins. BMC Biotechnol 2013;10:13-40
37. Floss DM, Schallau K, Rose-John S, et al. Elastin-like polypeptides revolutionize recombinant protein expression and their biomedical application. Trends Biotechnol 2010;28(1):37-45
38. Conley AJ, Joensuu JJ, Jevnikar AM, et al. Optimization of elastin-like polypeptide fusions for expression and purification of recombinant proteins in plants. Biotechnol Bioeng 2009;103(3):562-73
39. Floss DM, Mockey M, Zanello G, et al. Expression and Immunogenicity of the Mycobacterial Ag85B/ESAT-6 antigens produced in transgenic plants by elastin-like peptide fusion strategy. J Biomed Biotechnol 2010;2010:1-14
40. Phan HT, Pohl J, Floss DM, et al. ELPylated haemagglutinins in tobacco plants induce potentially neutralizing antibodies against H5N1 viruses in mice. Plant Biotechnol J 2013;11(5):582-93
41. Conley AJ, Joensuu JJ, Richman A, Menassa R. Protein body-inducing fusions for high-level production and purification of recombinant proteins in plants. Plant Biotechnol J 2011;9(4):419-33
42. Joensuu JJ, Conley AJ, Lienemann M, et al. Hydrophobin fusion for high-level transient protein expression and purification in Nicotiana Benthamiana. Plant Physiol 2010;152(2):622-33
43. Gleba Y, Marillonnet S, Klimyuk V. Engineering viral expression vectors for plants: the 'full virus' and the 'deconstructed virus' strategies. Curr Opin Plant Biol 2004;7(2):182-8
44. Gleba Y, Klimyuk V, Marillonnet S. Magnifection - a new platform for expressing recombinant vaccines in plants. Vaccine 2005;23(17-18):2042-8
45. Landry N, Ward BJ, Trépanier S, et al. Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza. PLoS One 2010;5(12):e15559
46. Huang Z, Chen Q, Hjelm B, et al. A DNA replicon system for rapid high-level production of virus-like particles in plants. Biotechnol Bioeng 2009;103(4):706-14
47. Regnard GL, Halley-Stott RP, Tanzer FL, et al. High level protein expression in plants through the use of a novel autonomously replicating geminivirus shuttle vector. Plant Biotechnol J 2010;8(1):38-46
48. Yusibov V, Streatfield SJ, Kushnir N, et al. Hybrid viral vectors for vaccine and antibody production in plants. Curr Pharm Des 2013;19(31):5574-86
49. Farmacule (2009). Available from: www.ctcb.qut.edu.au/programs/farmacule.jsp
50. Rybicki EP. Plant-made vaccines for humans and animals. Plant Biotechnol J 2010;8(5):620-37
51. Peyret H, Lomonossoff GP. The pEAQ vector series: the easy and quick way to produce recombinant proteins in plants. Plant Mol Biol 2013;83(1-2):51-8
52. Sainsbury F, Thuenemann EC, Lomonossoff GP. pEAQ: versatile expression vectors for easy and quick transient expression of heterologous proteins in plants. Plant Biotechnol J 2009;7(7):682-93
53. Webster DE, Wang L, Mulcair M, et al. Production and characterization of an oral immunogenic Plasmodium antigen in plants using a virus-based expression system. Plant Biotechnol J 2009;7(9):846-55
54. Musiychuk K, Stephenson N, Bi H, et al. A launch vector for the production of vaccine antigens in plants. Influenza Other Respir Viruses 2007;1(1):19-25
55. Massa S, Franconi R, Brandi R, et al. Anti-cancer activity of plant-produced HPV16 E7 vaccine. Vaccine 2007;25(16):3018-21
56. Mett V, Musiychuk K, Bi H, et al. A plant produced influenza subunit vaccine protects ferrets against virus challenge. Influenza Other Respir Viruses 2008;2(1):33-40
57. Hefferon KL. Plant virus expression vectors set the stage as production platforms for biopharmaceutical proteins. Virology 2012;433(1):1-6
58. Fujiki M, Kaczmarczyk JF, Yusibov V, Rabindran S. Development of a new cucumber mosaic virus-based plant expression vector with truncated 3a movement protein. Virology 2008;381(1):136-42
59. López-Macías C. Virus-like particle (VLP)-based vaccines for pandemic influenza: performance of a VLP vaccine during the 2009 influenza pandemic. Hum Vaccinn Immunother 2012;8(3):411-14
60. Chen Q, Lai H. Plant-derived virus-like particles as vaccines. Hum Vaccinn Immunother 2013;9(1):26-49
61. Norja P, Lassila R, Makris M. Parvovirus transmission by blood products - a cause for concern? Br J Haematol 2012;159(4):385-93
62. Vianna GR, Cunha NB, Murad AM, et al. Soybeans as bioreactors for biopharmaceuticals and industrial proteins. Genet Mol Res 2011;10(3):1733-52
63. Karimi F, Mousavi A, Hatef-Salmanian A, et al. Immunogenicity of EIT chimeric protein expressed in transplastomic tobacco plants towards development of an oral vaccine against Escherichia coli O157:H7. Plant Biotechnol Rep 2013;7(4):535-46
64. Rubio-Infante N, Govea-Alonso DO, Alpuche-Solís AG, et al. A chloroplast-derived C4V3 polypeptide from the human immunodeficiency virus (HIV) is orally immunogenic in mice. Plant Mol Biol 2012;78(4-5):337-49
65. Peréz Aguirreburualde MS, Gómez MC, Ostachuk A, et al. Efficacy of a BVDV subunit vaccine produced in alfalfa transgenic plants. Vet Immunol Immunopathol 2013;151(3-4):315-24
66. Hu J, Ni Y, Dryman BA, et al. Immunogenicity study of plant-made oral subunit vaccine against porcine reproductive and respiratory syndrome virus (PRRSV). Vaccine 2012;30(12):2068-74
67. Penney CA, Thomas DR, Deen SS, Walmsley AM. Plant-made vaccines in support of the Millennium Development Goals. Plant Cell Rep 2011;30(5):789-98
68. Medicago Inc. (2013). Available from: www.medicago.com/English/Products/product-pipeline/default.aspx
69. Melnik S, Stoger E. Green factories for biopharmaceuticals. Curr Med Chem 2013;20(8):1038-46
70. Davies HM. Commercialization of whole-plant systems for biomanufacturing of protein products: evolution and prospects. Plant Biotechnol J 2010;8(8):845-61
71. Scotti N, Rybicki EP. Virus-like particles produced in plants as potential vaccines. Expert Rev Vaccines 2013;12(2):211-24
72. Streatfield SJ. Regulatory issues for plant-made pharmaceuticals and vaccines. Expert Rev Vaccines 2005;4(4):591-601
73. Hefferon K. Plant-derived pharmaceuticals for the developing world. Biotechnol J 2013;8(10):1193-202
74. Rosales-Mendoza S, Govea-Alonso DO, Monreal-Escalante E, et al. Developing plant-based vaccines against neglected tropical diseases: where are we? Vaccine 2012;31(1):40-8
75. Vamvaka E, Twyman RM, Christou P, Capell T. Can plant biotechnology help to break the HIV-malaria link? Biotechnol Adv 2014;32(3):575-82
76. Ruhlman T, Ahangari R, Devine A, et al. Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts - oral administration protects against development of insulitis in non-obese diabetic mice. Plant Biotechnol J 2007;5(4):495-510
77. Rosales-Mendoza S. Can a plant-based vaccine treat hypertension? Med Hypotheses 2012;79(5):555-9
78. Salazar-González JA, Rosales-Mendoza S. A perspective for atherosclerosis vaccination: is there a place for plant-based vaccines? Vaccine 2013;31(10):1364-9
79. Zhou B, Zhang Y, Wang X, et al. Oral administration of plant-based rotavirus VP6 induces antigen-specific IgAs, IgGs and passive protection in mice. Vaccine 2010;28(37):6021-7
80. Van Dolleweerd CJ, Teh AY, Banyard AC, et al. Engineering, expression in transgenic plants and characterization of e559, a rabies virus-neutralizing monoclonal antibody. J Infect Dis 2014;210(2):200-8
81. Loza-Rubio E, Rojas-Anaya E, López J, et al. Induction of a protective immune response to rabies virus in sheep after oral immunization with transgenic maize, expressing the rabies virus glycoprotein. Vaccine 2012;30(37):5551-6
82. Ganapathy M, Perumal A, Mohan C, et al. Immunogenicity of Brugia malayi abundant larval transcript-2, a potential filarial vaccine candidate expressed in tobacco. Plant Cell Rep 2014;33(1):179-88
83. Uvarova EA, Belavin PA, Permyakova NV, et al. Oral Immunogenicity of plant-made Mycobacterium tuberculosis ESAT6 and CFP10. Biomed Res Int 2013;2013:316304
84. Lakshmi PS, Verma D, Yang X, et al. Low cost tuberculosis vaccine antigens in capsules: expression in chloroplasts, bio-encapsulation, stability and functional evaluation in vitro. PLoS One 2013;8(1):e54708
85. Huy NX, Kim SH, Yang MS, et al. Immunogenicity of a neutralizing epitope from porcine epidemic diarrhea virus: M cell targeting ligand fusion protein expressed in transgenic rice calli. Plant Cell Rep 2012;31(10):1933-42
86. Wang Y, Shen Q, Jiang Y, et al. Immunogenicity of foot-and-mouth disease virus structural polyprotein P1 expressed in transgenic rice. J Virol Methods 2012;181(1):12-17
87. Rao JP, Agrawal P, Mohammad R, et al. Expression of VP1 protein of serotype A and O of foot-and-mouth disease virus in transgenic sunnhemp plants and its immunogenicity for guinea pigs. Acta Virol 2012;56(2):91-9
88. Soria-Guerra RE, Rosales-Mendoza S, Moreno-Fierros L, et al. Oral immunogenicity of tomato-derived sDPT polypeptide containing Corynebacterium diphtheriae, Bordetella pertussis and Clostridium tetani exotoxin epitopes. Plant Cell Rep 2011;30(3):417-24
89. Rukavtsova EB, Chebotareva EN, Rudenko NV, Buryanov YI. Immunogenicity of biologically safe potato tubers synthesizing hepatitis B surface antigen. Dokl Biol Sci 2011;437:110-12
90. Ghiasi SM, Salmanian AH, Chinikar S, et al. Mice orally immunized with a transgenic plant expressing the glycoprotein of Crimean-Congo hemorrhagic fever virus. Clin Vaccine Immunol 2011;18(12):2031-7
91. Shoji Y, Chichester JA, Jones M, et al. Plant-based rapid production of recombinant subunit hemagglutinin vaccines targeting H1N1 and H5N1 influenza. Hum Vaccin 2011;7(Suppl):41-50
92. Govea-Alonso DO, Rubio-Infante N, García-Hernández AL, et al. Immunogenic properties of a lettuce-derived C4(V3)6 multiepitopic HIV protein. Planta 2013; 238(4):785-92
93. Hongli L, Xukui L, Ting L, et al. Transgenic tobacco expressed HPV16-L1 and LT-B combined immunization induces strong mucosal and systemic immune responses in mice. Hum Vaccin Immunother 2013;9(1):83-9
94. Rossi L, Dell'orto V, Vagni S, et al. Protective effect of oral administration of transgenic tobacco seeds against verocytotoxic Escherichia coli strain in piglets. Vet Res Commun 2014;38(1):39-49
95. Pasquevich KA, Ibañez AE, Coria LM, et al. An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice. PLoS One 2011;6(1):e16203
96. Gregory JA, Topol AB, Doerner DZ, et al. Alga-produced cholera toxin-Pfs25 fusion proteins as oral vaccines. Appl Environ Microbiol 2013;79(13):3917-25
97. Yiu JC, Liu CW, Su RY, et al. Immunogenicity of a lettuce-derived vaccine candidate expressing the E2 protein against classical swine fever virus. Plant Cell Tiss Organ Cult 2013;113(3):483-90
98. Festa M, Brun P, Piccinini R, et al. Staphylococcus aureus Efb protein expression in Nicotiana tabacum and immune response to oral administration. Res Vet Sci 2013;94(3):484-9
99. Hamorsky KT, Kouokam JC, Bennett LJ, et al. Rapid and scalable plant-based production of a cholera toxin B subunit variant to aid in mass vaccination against cholera outbreaks. PLoS Negl Trop Dis 2013;7(3):e2046
100. Karaman S, Cunnick J, Wang K. Expression of the cholera toxin B subunit (CT-B) in maize seeds and a combined mucosal treatment against cholera and traveler's diarrhea. Plant Cell Rep 2012;31(3):527-37
101. Davoodi-Semiromi A, Schreiber M, Nalapalli S, et al. Chloroplast-derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery. Plant Biotechnol J 2010;8(2):223-42
102. Zhang XX, Yu H, Wang XH, et al. Protective efficacy against Chlamydophila psittaci by oral immunization based on transgenic rice expressing MOMP in mice. Vaccine 2013;31(4):698-703
103. Betancourt MA, de Aluja AS, Sciutto E, et al. Effective protection induced by three different versions of the porcine S3Pvac anticysticercosis vaccine against rabbit experimental Taenia pisiformis cysticercosis. Vaccine 2012;30(17):2760-7
104. Zhang Y, Chen S, Li J, et al. Oral immunogenicity of potato-derived antigens to Mycobacterium tuberculosis in mice. Acta Biochim Biophys Sin (Shanghai) 2012;44(10):823-30
105. Del L, Yácono M, Farran I, et al. A chloroplast-derived Toxoplasma gondii GRA4 antigen used as an oral vaccine protects against toxoplasmosis in mice. Plant Biotechnol J 2012;10(9):1136-44
106. Salyaev RK, Rekoslavskaya NI, Stolbikov AS, et al. Candidate mucosal vaccine against hepatitis B based on tomatoes transgenic for the preS2-S gene. Dokl Biochem Biophys 2012;446:257-9
107. Ma C, Wang L, Webster DE, et al. Production, characterization and immunogenicity of a plant-made Plasmodium antigen - the 19 kDa C-terminal fragment of Plasmodium yoelii merozoite surface protein 1. Appl Microbiol Biotechnol 2012;94(1):151-61
108. Chan HT, Chia MY, Pang VF, et al. Oral immunogenicity of porcine reproductive and respiratory syndrome virus antigen expressed in transgenic banana. Plant Biotechnol J 2013;11(3):315-24
109. Martínez-González L, Rosales-Mendoza S, Soria-Guerra RE, et al. Oral immunization with a lettuce-derived Escherichia coli heat-labile toxin B subunit induces neutralizing antibodies in mice. Plant Cell Tiss Organ Cult 2011;107:441-9
110. Pelosi A, Piedrafita D, De Guzman G, et al. The effect of plant tissue and vaccine formulation on the oral immunogenicity of a model plant-made antigen in sheep. PLoS One 2012;7(12):e52907
111. Ye YJ, Li WG. The study on immune responses in BALB/c mice by immunization with the transgenic alfalfa (Medicago sativa) containing Eg95-EgA31 fusion gene of Echinococcus granulosus. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2010;26(8):750-3
112. Chia MY, Hsiao SH, Chan HT, et al. Immunogenicity of recombinant GP5 protein of porcine reproductive and respiratory syndrome virus expressed in tobacco plant. Vet Immunol Immunopathol 2010;135(3-4):234-43
113. Dreesen IA, Charpin El, Hamri G, et al. Heat-stable oral alga-based vaccine protects mice from Staphylcoccus aureus infection. J Biotechnol 2010;145(3):273-80
114. Kopertekh L, Broer I, Schiemann J. A developmentally regulated Cre- lox. In: Dunwell JM, Wetten CA, editors. Transgenic plants methods and protocols. School of Biological Sciences University of Reading, Humana Press; London, UK: 2012. p. 335-50
115. Ebinuma H, Nanto K, Kasahara S, Komamine A. Marker-free gene targeting by recombinase-mediated cassette exchange. In: Dunwell JM, Wetten CA, editors. Transgenic plants methods and protocols. School of Biological Sciences University of Reading, Humana Press; London, UK: 2012. p. 377-90
116. Wakasa Y, Takaiwa F. Use of a callus-specific selection system to develop transgenic rice seed accumulating a high level of recombinant protein. In: Dunwell JM, Wetten CA, editors. Transgenic plants methods and protocols. School of Biological Sciences University of Reading, Humana Press; London, UK: 2012. p. 467-79
117. Ferradini N, Nicolia A, Capomaccio S, et al. Assessment of simple marker-free genetic transformation techniques in alfalfa. Plant Cell Rep 2011;30(11):1991-2000
118. Mátic S, Masenga V, Poli A, et al. Comparative analysis of recombinant Human Papillomavirus 8 L1 production in plants by a variety of expression systems and purification methods. Plant Biotechnol J 2012;10(4):410-21
119. Matić S, Rinaldi R, Masenga V, Noris E. Efficient production of chimeric human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants. BMC Biotechnol 2011;11:106
120. Thuenemann EC, Lenzi P, Love AJ, et al. The use of transient expression systems for the rapid production of virus like particles in plants. Curr Pharm Des 2013;19(31):5564-73
121. Inka Borchers AM, Gonzalez-Rabade N, Gray JC. Increased accumulation and stability of rotavirus VP6 protein in tobacco chloroplasts following changes to the 5′ untranslated region and the 5′ end of the coding region. Plant Biotechnol J 2012;10(4):422-34
122. Gorantala J, Grover S, Rahl A, et al. Generation of protective immune response against anthrax by oral immunization with protective antigen plant-based vaccine. J Biotechnol 2014;176:1-10
123. Yang Y, Li X, Yang H, et al. Immunogenicity and virus-like particle formation of rotavirus capsid proteins produced in transgenic plants. Sci China Life Sci 2011;54(1):82-9
124. Pniewski T, Kapusta J, Bocia¸g P, et al. Low-dose oral immunization with lyophilized tissue of herbicide-resistant lettuce expressing hepatitis B surface antigen for prototype plant-derived vaccine tablets formulation. J Appl Genet 2011;52(2):125-36
125. Lai H, Chen Q. Bioprocessing of plant-derived particles of Norwalk virus capsid protein under current Good Manufacture Practice regulations. Plant Cell Rep 2012;31(3):573-84
126. Love AJ, Chapman SN, Matic S, et al. In planta production of a candidate vaccine against bovine papillomavirus type 1. Planta 2012;236(4):1305-13
127. Pniewski T, Kapusta J, Bocia¸g P, et al. Plant expression, lyophilisation and storage of HBV medium and large surface antigens for a prototype oral vaccine formulation. Plant Cell Rep 2012;31(3):585-95
128. Jones RM, Chischester JA, Mett V, et al. A plant-produced Pfs25 VLP malaria vaccine candidate induces persistent transmission blocking antibodies against Plasmodium falciparum in immunized mice. PLoS One 2013;8(11):e79538
129. Kessans SA, Linhart MD, Matoba N, Mor T. Biological and biochemical characterization of HIV-1 Gag/dgp41 virus-like particles expressed in Nicotiana benthamiana. Plant Biotechnol J 2013;11(6):681-90
130. Pineo CB, Hitzeroth II, Rybicki EP. Immunogenic assessment of plant-produced human papillomavirus type 16 L1/L2 chimeras. Plant Biotechnol J 2013;11(8):964-75
131. Thuenemann EC, Meyers AE, Verwey J, et al. A method for rapid production of heteromultimeric protein complex in plants. Plant Biotechnol J 2013;11(7):839-46
132. Monroy-García A, Gómez-Lim MA, Weiss-Steider B, et al. Immunization with an HPV-16 L1-based chimeric virus-like particle containing HPV-16 E6 and E7 epitopes elicits long-lasting prophylactic and therapeutic efficacy in an HPV-16 tumor mice model. Arch Virol 2014;159(2):291-305